NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).
2018 ◽
Vol 36
(15_suppl)
◽
pp. 8537-8537
◽
Keyword(s):
Phase Ii
◽